Nicotine occurrence in bottled mineral water: Analysis of 10 brands of water in Spain

Science of the Total Environment

Volumn 416, Issue , 2012, Pages 527-531

  Gonzalez Alonso S ^a   Valcarcel Y ^a   Montero, J C ^b   Catala M ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b Castilla La Mancha Regional Health and Social Welfare Authority   (Spain)

Author keywords

Bottled mineral water; Nicotine; Pharmaceuticals; Spain

Indexed keywords

BOTTLED WATER; HEALTHY HUMANS; HUMAN HEALTH RISKS; LOW LEVEL; MINERAL WATER; NICOTINE; ORAL INTAKE; PHARMACEUTICAL COMPOUNDS; PHARMACEUTICALLY ACTIVE COMPOUNDS; PREGNANT WOMAN; QUALITY CHARACTERISTIC; SPAIN;

AQUIFERS; BEVERAGES; DRUG PRODUCTS; GROUNDWATER POLLUTION; HEALTH; HEALTH RISKS; HYDROGEOLOGY; PYRIDINE; RISK ASSESSMENT; SILICATE MINERALS; WATER SUPPLY;

POTABLE WATER;

MINERAL WATER; NICOTINE;

AQUIFER; CONCENTRATION (COMPOSITION); DRINKING WATER; DRUG; HEALTH RISK; RISK ASSESSMENT; WATER QUALITY; WATER SUPPLY;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRINKING; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; HEALTH HAZARD; HUMAN; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPAIN; WATER ANALYSIS; WATER POLLUTION; WATER QUALITY; WATER SAMPLING; WATER SUPPLY;

DRINKING WATER; HUMANS; NICOTINE; SPAIN;

SPAIN;

EID: 84856212680     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2011.11.046     Document Type: Article

References (23)

1. Andersson C., Weenström P., Gry J. Nicotine alkaloids in Solanaceous food plants. TemaNord 2003, 531.
2. Benotti M.J., Brownawell B.J. Distributions of pharmaceuticals in an urban estuary during both dry- and wet-weather conditions. Environ Sci Technol 2007, 41:5795-5802.
3. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 2009, 43:597-603.
4. Besunder J.B., Reed M.D., Blumer J.L. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I). Clin Pharmacokinet 1988, 14:189-216.
5. Bradley P.M., Barber L.B., Kolpin D.W., McMahon P.B., Chapelle F.H. Biotransformation of caffeine, cotinine, and nicotine in stream sediments: implications for use as wastewater indicators. Environ Toxicol Chem 2007, 26:1116-1121.
6. Bruce G.M., Pleus R.C., Snyder S.A. Toxicological relevance of pharmaceuticals in drinking water. Environ Sci Technol 2010, 44:5619-5626.
7. Buerge I.J., Kahle M., Buser H.R., Muller M.D., Poiger T. Nicotine derivatives in wastewater and surface waters: application as chemical markers for domestic wastewater. Environ Sci Technol 2008, 42:6354-6360.
8. EEA Pharmaceuticals in the environment results of an EEA workshop 2010, European Environment Agency, Luxembourg. http://www.eea.europa.eu/publications/pharmaceuticals-in-the-environment-result-of-an-eea-workshop/at_download/file.
9. Huerta-Fontela M., Galceran M.T., Ventura F. Ultraperformance liquid chromatography-tandem mass spectrometry analysis of stimulatory drugs of abuse in wastewater and surface waters. Anal Chem 2007, 79:3821-3829.
10. Huerta-Fontela M., Galceran M.T., Ventura F. Stimulatory drugs of abuse in surface waters and their removal in a conventional drinking water treatment plant. Environ Sci Technol 2008, 42:6809-6816.
11. Hussein J., Farkas S., MacKinnon Y., Ariano R.E., Sitar D.S., Hasan S.U. Nicotine dose-concentration relationship and pregnancy outcomes in rat: biologic plausibility and implications for future research. Toxicol Appl Pharmacol 2007, 218:1-10.
12. Kumar A., Xagoraraki I. Human health risk assessment of pharmaceuticals in water: an uncertainty analysis for meprobamate, carbamazepine, and phenytoin. Regul Toxicol Pharmacol 2010, 57:146-156.
13. Madriazo García G., Mato Miguel J. Actas del XI coloquio de geografía rural. Los espacios rurales entre hoy y el mañana 2002, Universidad de Cantabria, Santander.
14. Martinez Bueno M., Aguera A., Gómez M., Hernando M., García-Reyes J., Fernández-Alba A.R. Application of liquid chromatography/quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater. Anal Chem 2007, 79:9372-9384.
15. Martinez Bueno M., Hernando M., Herrera S., Gómez M., Fernández-Alba A., Bustamante I., et al. Pilot survey of chemical contaminants from industrial and human activities in river waters in Spain. Int J Environ Anal Chem 2010, 90:321-343.
16. Mompelat S., Le B.B., Thomas O. Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. Environ Int 2009, 35:803-814.
17. Rakic V., Damjanovic L., Rac V., Stosic D., Dondur V., Auroux A. The adsorption of nicotine from aqueous solutions on different zeolite structures. Water Res 2010, 44:2047-2057.
18. Schneider T., Bizarro L., Asherson P.J., Stolerman I.P. Gestational exposure to nicotine in drinking water: teratogenic effects and methodological issues. Behav Pharmacol 2010, 21:206-216.
19. Singer J., Janz T. Apnea and seizures caused by nicotine ingestion. Pediatr Emerg Care 1990, 6:135-137.
20. US EPA Contaminant candidate list 3 (CCL3) 2009, United States Environmental Protection Agency, Washington, DC.
21. Vorosmarty C.J., Green P., Salisbury J., Lammers R.B. Global water resources: vulnerability from climate change and population growth. Science 2000, 289:284-288.
22. Yildiz D. Nicotine, its metabolism and an overview of its biological effects. Toxicon 2004, 43:619-632.
23. Zwiener C. Occurrence and analysis of pharmaceuticals and their transformation products in drinking water treatment. Anal Bioanal Chem 2007, 387:1159-1162.